Doctor profile · Federal record
Dr. Mark Dawkins, MD
Dermatology Physician (CMS: Dermatology) · Oklahoma City, OK
- NPI 1114909405
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 32 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
13174 N Macarthur Blvd
Oklahoma City, OK 731423017
(405) 721-5555
fax (405) 470-7093 - Mailing address
-
Dept 96-0317
Oklahoma City, OK 731960317
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- July 21, 2022
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Oklahoma #19539
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114909405. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,961
Distinct HCPCS
10
Medicare allowed
$382,567
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,498 | 368 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,473 | 971 | $85 | |
17110 |
Destruction of skin growth, 1-14 growths | 838 | 623 | $102 | |
17000 |
Destruction of precancer skin growth, 1 growth | 817 | 537 | $43 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 441 | 334 | $120 | |
11102 |
Biopsy of related skin growth, first growth | 290 | 243 | $73 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 91 | 24 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 88 | 78 | $53 | |
11103 |
Biopsy of related skin growth, each additional growth | 62 | 50 | $47 | |
11200 |
Removal of skin tag, 1-15 skin tags | 45 | 41 | $45 |
In context: peer comparison
Among 17 peers in Oklahoma City Dermatology Physician, average services per provider: 233. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$16,157
Transactions
173
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 37 | $13,143.91 | |
| Lilly USA, LLC | 18 | $404.18 | |
| Novartis Pharmaceuticals Corporation | 15 | $303.71 | |
| E.R. Squibb & Sons, L.L.C. | 15 | $293.85 | |
| Ucb, INC. | 9 | $284.18 | |
| Janssen Biotech, INC. | 8 | $275.41 | |
| Amgen INC. | 12 | $248.69 | |
| Pfizer INC. | 10 | $216.43 | |
| Genzyme Corporation | 10 | $214.82 | |
| Arcutis Biotherapeutics, INC. | 16 | $201.56 | |
| Leo Pharma INC. | 10 | $193.86 | |
| Regeneron Healthcare Solutions, INC. | 4 | $109.06 | |
| Biofrontera INC. | 4 | $69.97 | |
| Sun Pharmaceutical Industries INC. | 3 | $58.96 | |
| Krystal Biotech INC | 2 | $39.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
777
Patients
459
Total drug cost
$34,494
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Doxycycline Hyclate | Generic | 162 | 58 | $3,849 |
| Clobetasol Propionate | Generic | 107 | 62 | $7,797 |
| Triamcinolone Acetonide | Generic | 91 | 72 | $1,306 |
| Fluorouracil | Generic | 82 | 76 | $8,304 |
| Metronidazole | Generic | 40 | 32 | $4,123 |
| Minoxidil | Generic | 38 | 14 | $462 |
| Imiquimod | Generic | 37 | 27 | $2,731 |
| Fluconazole | Generic | 32 | 15 | $964 |
| Mupirocin | Generic | 32 | 29 | $376 |
| Betamethasone Dipropionate | Generic | 30 | 27 | $1,661 |
Frequently asked questions
What is Dr. Mark Dawkins's medical specialty?
Dr. Mark Dawkins practices Dermatology Physician in Oklahoma City, OK.
Where does Dr. Mark Dawkins practice?
Dr. Mark Dawkins practices at 13174 N Macarthur Blvd, Oklahoma City, OK 731423017. Office phone: 4057215555.
What is Dr. Mark Dawkins's NPI?
Dr. Mark Dawkins's National Provider Identifier (NPI) is 1114909405, issued by NPPES.
Does Dr. Mark Dawkins accept Medicare assignment?
Yes. Dr. Mark Dawkins accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Dawkins commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.